The Multifaceted Roles of B Cells in Solid Tumors: Emerging Treatment Opportunities

被引:32
作者
Flynn, Nicole J. [1 ,2 ]
Somasundaram, Rajasekharan [3 ]
Arnold, Kimberly M. [1 ,4 ]
Sims-Mourtada, Jennifer [1 ,2 ,4 ]
机构
[1] Christiana Care Hlth Serv Inc, Helen F Graham Canc Ctr & Res Inst, Ctr Translat Canc Res, 4701 Ogletown Stanton Rd,Suite 4300, Newark, DE 19713 USA
[2] Univ Delaware, Dept Biol Sci, Newark, DE 19716 USA
[3] Wistar Inst Anat & Biol, Melanoma Res Ctr, 3601 Spruce St, Philadelphia, PA 19104 USA
[4] Univ Delaware, Dept Med Lab Sci, Newark, DE 19716 USA
基金
美国国家卫生研究院;
关键词
CD8(+) T-CELLS; TERTIARY LYMPHOID STRUCTURES; INFILTRATING PLASMA-CELLS; HUMORAL IMMUNE-RESPONSE; BREAST-CANCER PATIENTS; IMMUNOGLOBULIN-KAPPA C; AGONIST CD40 ANTIBODY; SERUM P53 ANTIBODY; PROGNOSTIC VALUE; POOR-PROGNOSIS;
D O I
10.1007/s11523-017-0481-x
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The influence of tumor infiltrating lymphocytes on tumor growth and response to therapy is becoming increasingly apparent. While much work has focused on the role of T cell responses in anti-tumor immunity, the role of B cells in solid tumors is much less understood. Tumor infiltrating B cells have been found in a variety of solid tumors, including breast, ovarian, prostate, melanoma, and colorectal cancer. The function of B cells in solid tumors is controversial, with many studies reporting a pro-tumor effect, while other studies demonstrate a role for B cells in the anti-tumor immune response. In this review, we discuss the prognostic ability of B cells in solid tumors as well as the mechanisms by which B cells can either promote or suppress anti-tumor immunity. Additionally, we review current therapeutic strategies that may target both pro- and anti-tumor B cells.
引用
收藏
页码:139 / 152
页数:14
相关论文
共 170 条
[51]   Antibody immunity to the p53 oncogenic protein is a prognostic indicator in ovarian cancer [J].
Goodell, V ;
Salazar, LG ;
Urban, N ;
Drescher, CW ;
Gray, H ;
Swensen, RE ;
McIntosh, MW ;
Disis, ML .
JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (05) :762-768
[52]   PD-L1 is a critical mediator of regulatory B cells and T cells in invasive breast cancer [J].
Guan, Honggeng ;
Wan, Yuqiu ;
Lan, Jing ;
Wang, Qin ;
Wang, Zhangyu ;
Li, Yecheng ;
Zheng, Jiqing ;
Zhang, Xueguang ;
Wang, Zemin ;
Shen, Yueping ;
Xie, Fang .
SCIENTIFIC REPORTS, 2016, 6
[53]   PD-L1 mediated the differentiation of tumor-infiltrating CD19+ B lymphocytes and T cells in Invasive breast cancer [J].
Guan, Honggeng ;
Lan, Yang ;
Wan, Yuqiu ;
Wang, Qin ;
Wang, Cheng ;
Xu, Longjiang ;
Chen, Yongjing ;
Liu, Wenting ;
Zhang, Xueguang ;
Li, Yecheng ;
Gu, Yongping ;
Wang, Zemin ;
Xie, Fang .
ONCOIMMUNOLOGY, 2016, 5 (02)
[54]   Prognostic evaluation of the B cell/IL-8 metagene in different intrinsic breast cancer subtypes [J].
Hanker, Lars C. ;
Rody, Achim ;
Holtrich, Uwe ;
Pusztai, Lajos ;
Ruckhaeberle, Eugen ;
Liedtke, Cornelia ;
Ahr, Andre ;
Heinrich, Tomas M. ;
Saenger, Nicole ;
Becker, Sven ;
Karn, Thomas .
BREAST CANCER RESEARCH AND TREATMENT, 2013, 137 (02) :407-416
[55]   Antigen-specific IgG antibodies in stage IV long-time survival breast cancer patients [J].
Hansen, MH ;
Ostenstad, B ;
Sioud, M .
MOLECULAR MEDICINE, 2001, 7 (04) :230-239
[56]   The tumor-infiltrating B cell response in medullary breast cancer is oligoclonal and directed against the autoantigen actin exposed on the surface of apoptotic cancer cells [J].
Hansen, MH ;
Nielsen, H ;
Ditzel, HJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (22) :12659-12664
[57]  
Harada K, 2014, INT J HEPATOL, V2014
[58]   Serum exosomes and cytokines promote a T-helper cell type 2 environment in the peripheral blood of glioblastoma patients [J].
Harshyne, Larry A. ;
Nasca, Brian J. ;
Kenyon, Lawrence C. ;
Andrews, David W. ;
Hooper, D. Craig .
NEURO-ONCOLOGY, 2016, 18 (02) :206-215
[59]   Leukocyte infiltration and tumor cell plasticity are parameters of aggressiveness in primary cutaneous melanoma [J].
Hillen, Femke ;
Baeten, Coen I. M. ;
van de Winkel, Anouk ;
Creytens, David ;
van der Schaft, Daisy W. J. ;
Winnepenninckx, Veronique ;
Griffioen, Arjan W. .
CANCER IMMUNOLOGY IMMUNOTHERAPY, 2008, 57 (01) :97-106
[60]   Tumor-Infiltrating CD8+ T Lymphocytes Associated With Clinical Outcome in Anal Squamous Cell Carcinoma [J].
Hu, Wan-Hsiang ;
Miyai, Katsumi ;
Cajas-Monson, Luis C. ;
Luo, Linda ;
Liu, Lin ;
Ramamoorthy, Sonia L. .
JOURNAL OF SURGICAL ONCOLOGY, 2015, 112 (04) :421-426